サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1629173

細胞生存率アッセイの世界市場：製品種類別・細胞の種類別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Cell Viability Assays Market, By Product Type, By Cell Type, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 397 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
細胞生存率アッセイの世界市場：製品種類別・細胞の種類別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2024年11月02日
発行: AnalystView Market Insights
ページ情報: 英文 397 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

細胞生存率アッセイの市場規模は、2024年に17億5,634万米ドルとなり、2025年から2032年にかけてCAGR 7.5%で拡大

細胞生存率アッセイの市場力学

個別化医療に対する需要の高まりが細胞生存率アッセイ市場の成長を促進

個別化医療に対する需要の高まりは、細胞生存率アッセイ市場の成長を大きく後押ししています。細胞生存率アッセイは、細胞の健康状態、薬剤反応、治療の可能性を評価する上で重要な役割を果たすからです。米国国立衛生研究所 (NIH) によると、細胞生存率試験は、特に腫瘍学における新規治療の有効性を理解する上で極めて重要です。このため、製薬会社や研究機関は、薬剤開発を最適化するための高度なアッセイ技術に多額の投資を行っています。近年では、MTTやMTSアッセイのようなツールが、潜在的な薬剤候補のスクリーニングや標的治療の補助に人気を博しています。2021年、主要バイオ医薬品企業は、個別化治療レジメンの改善に特化した研究開発予算が18%増加したと報告し、業界における細胞生存率アッセイの重要性が高まっていることを強調しました。精密医療と細胞ベースの治療への注目が高まる中、バイオテクノロジーと医薬品におけるイノベーションに後押しされ、同市場は今後も上昇基調を続けると予想されます。

細胞生存率アッセイ市場：主な考察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間 (2025-2032年) に約7.5%のCAGRで毎年成長すると推定されます。

製品種類別では、消耗品が2024年に最大の市場シェアを示すと予測されています。

細胞の種類別では、ヒト細胞が2024年の主要細胞タイプです。

地域別では、北米が2024年の売上高をリード

細胞生存率アッセイ市場：セグメンテーション分析

細胞生存率アッセイの世界市場は、製品種類、細胞の種類、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場は製品種類別によって2つのカテゴリーに分けられます：消耗品と装置です。消耗品は、進行中の研究や臨床検査で頻繁に使用されるため、細胞生存率アッセイ市場で高い市場シェアを占めています。装置は、必要不可欠ではありますが、交換頻度は低く、一般的に専門的な研究環境や高度なラボで利用されます。

市場は細胞の種類によって2つのカテゴリーに分けられます：ヒト細胞と微生物細胞です。ヒト細胞は、個別化医療、がん研究、医薬品開発において重要な役割を果たすため、細胞生存率アッセイ市場の大半を占めています。微生物細胞は、特定の用途では重要ですが、シェアは小さく、主に微生物学とバイオテクノロジー研究で使用されます。

細胞生存率アッセイ市場：地域別分析

世界の細胞生存率アッセイ市場は、バイオテクノロジーの進歩や慢性疾患の増加により、様々な地域で成長を遂げています。北米は、米国における研究機関、バイオ製薬企業、医療機関の強い存在感が主因で市場をリードしています。同地域は、医療と医薬品、特に医薬品開発と個別化医療への高い投資から利益を得ています。欧州がこれに続き、幹細胞研究やがん治療薬に力を入れているドイツや英国などが大きく貢献しています。アジア太平洋地域は、政府の主導で医療の進歩が推進されている中国やインドのような新興経済国での研究活動の活発化により、急速に地歩を固めています。これらの地域ではバイオテクノロジー企業や製薬企業が増加しており、市場の成長をさらに後押ししています。さらに、中南米と中東の市場は、医療ニーズの高まりと診断・臨床研究インフラの改善によって拡大しています。このように、これらの地域は細胞生存率アッセイ市場にとって有利な機会を提供しています。

細胞生存率アッセイ市場：競合情勢

細胞生存率アッセイ市場の競合情勢は、老舗世界企業と新興バイオテクノロジー企業が混在しているのが特徴です。主要企業には、サーモフィッシャーサイエンティフィック、バイオ・ラッド・ラボラトリーズ、パーキンエルマー、プロメガ・コーポレーションなどがあり、幅広い製品ポートフォリオと強力な研究開発力によって市場を独占しています。これらの企業は、創薬、幹細胞研究、臨床診断など様々な用途向けに幅広い消耗品や機器を提供しています。同市場ではまた、製品ラインアップや地理的プレゼンスを拡大するために、提携や合併、買収が増加しています。中小企業は市場シェアを拡大するため、ニッチな用途と技術革新に注力しています。企業は、個別化医療や標的治療に対する需要の高まりに対応するため、先進的なハイスループット細胞生存率アッセイの開発に投資しています。研究開発活動が重視されるようになり、バイオテクノロジーのイノベーションに対する資金調達が増加していることも、市場競争の激化に寄与しています。

目次

第1章 細胞生存率アッセイ市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 細胞生存率アッセイの主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 細胞生存率アッセイ市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 細胞生存率アッセイ市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 細胞生存率アッセイの市場情勢

  • 細胞生存率アッセイの市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 細胞生存率アッセイ市場：製品種類別

  • 概要
    • セグメント別シェア分析：製品種類別
    • 消耗品
      • 試薬
      • アッセイキット
      • 色素排除アッセイ
      • 比色分析
      • 蛍光アッセイ
      • 発光アッセイ
      • マイクロプレート
    • 装置
      • 分光光度計
      • 顕微鏡検査
      • 細胞イメージング・分析システム
      • フローサイトメトリー
    • その他

第8章 細胞生存率アッセイ市場：細胞の種類別

  • 概要
    • セグメント別シェア分析：細胞の種類別
    • ヒト細胞
    • 微生物細胞

第9章 細胞生存率アッセイ市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • 創薬・医薬品開発
    • 幹細胞研究
    • 臨床・診断用途
    • その他

第10章 細胞生存率アッセイ市場：エンドユーザー別

  • 概要
    • セグメント別シェア分析：エンドユーザー別
    • 研究機関・学術センター
    • 製薬・バイオテクノロジー企業
    • 病院・診療所
    • その他

第11章 細胞生存率アッセイ市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋 (APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ (LATAM)
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ (MEA)
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析：細胞生存率アッセイ業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Abcam plc
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • Biotium
    • BioVision, Inc.
    • Cayman Chemical Company
    • Cell Biolabs, Inc.
    • Cell Signaling Technology, Inc.
    • Charles River Laboratories
    • Creative Bioarray
    • Merck KGaA
    • PerkinElmer, Inc.
    • Promega Corporation
    • Sigma-Aldrich (Merck)
    • Thermo Fisher Scientific, Inc.
    • Others

第13章 AnalystViewの全方位的分析

目次
Product Code: ANV4498

REPORT HIGHLIGHT

Cell Viability Assays Market size was valued at US$ 1,756.34 Million in 2024, expanding at a CAGR of 7.5% from 2025 to 2032.

The Cell Viability Assays Market refers to the segment of the biotechnology and pharmaceutical industry that provides various assays used to assess the health, growth, and survival of cells in culture. These assays are crucial for drug discovery, toxicity testing, and cancer research. Factors such as the increasing demand for personalized medicine, advancements in biotechnology, and the rising prevalence of chronic diseases like cancer are propelling market growth. Moreover, the growing focus on cell-based therapies and regenerative medicine has enhanced the need for reliable cell viability testing. In 2021, the global cancer burden reached over 19 million new cases, driving research investments that rely on these assays. However, limitations in assay sensitivity and the high cost of advanced assays are expected to restrain the market's growth. Opportunities lie in the rising adoption of 3D cell culture models, improvements in assay technologies, and increasing collaborations between pharmaceutical companies and research institutions. Additionally, emerging markets, particularly in Asia Pacific, present significant growth potential due to expanding healthcare infrastructure.

Cell Viability Assays Market- Market Dynamics

Rising Demand for Personalized Medicine Fuels Growth in the Cell Viability Assays Market

The increasing demand for personalized medicine has significantly boosted the growth of the Cell Viability Assays Market, as these assays play a crucial role in assessing cell health, drug responses, and therapeutic potential. According to the National Institutes of Health (NIH), cell viability testing is critical for understanding the effectiveness of new treatments, especially in oncology. This has driven pharmaceutical companies and research institutions to invest heavily in advanced assay technologies to optimize drug development. In recent years, tools like MTT and MTS assays have gained popularity in screening potential drug candidates and aiding in targeted therapies. In 2021, a leading biopharmaceutical company reported an 18% increase in its R&D budget dedicated to improving personalized treatment regimens, highlighting the growing significance of cell viability assays in the industry. With an expanding focus on precision medicine and cell-based therapies, the market is expected to continue its upward trajectory, fueled by innovations in biotechnology and pharmaceuticals.

Cell Viability Assays Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.5% over the forecast period (2025-2032)

Based on product type segmentation, Consumables was predicted to show maximum market share in the year 2024

Based on Cell Type segmentation, Human cells were the leading Cell Type in 2024

Based on region, North America was the leading revenue generator in 2024

Cell Viability Assays Market- Segmentation Analysis:

The Global Cell Viability Assays Market is segmented based on Product Type, Cell Type, Application, End-User, and Region.

The market is divided into two categories based on product type: Consumables and Instruments. Consumables hold a higher market share in the Cell Viability Assays Market due to their frequent use in ongoing research and clinical testing. Instruments, while essential, are less frequently replaced and are typically utilized in specialized research settings or advanced laboratories.

The market is divided into two categories based on Cell Type: Human cells and Microbial cells. Human cells dominate the Cell Viability Assays Market due to their critical role in personalized medicine, cancer research, and drug development. Microbial cells, while important in certain applications, hold a smaller share, primarily used in microbiology and biotechnology research.

Cell Viability Assays Market- Geographical Insights

The global Cell Viability Assays Market is experiencing growth across various regions, driven by advancements in biotechnology and the increasing prevalence of chronic diseases. North America leads the market, primarily due to the strong presence of research institutions, biopharmaceutical companies, and healthcare organizations in the U.S. The region benefits from high investments in healthcare and pharmaceuticals, particularly in drug development and personalized medicine. Europe follows closely, with significant contributions from countries like Germany and the U.K., which focus heavily on stem cell research and cancer therapeutics. The Asia-Pacific region is rapidly gaining ground, driven by increased research activities in emerging economies like China and India, where government initiatives are promoting healthcare advancements. The rise in biotechnology and pharmaceutical companies in these regions further boosts market growth. Additionally, the Latin American and Middle Eastern markets are expanding, fueled by growing healthcare needs and improvements in diagnostic and clinical research infrastructures. As such, these regions present lucrative opportunities for the cell viability assay market.

Cell Viability Assays Market- Competitive Landscape:

The competitive landscape of the Cell Viability Assays Market is characterized by a mix of well-established global players and emerging biotech companies. Key players include Thermo Fisher Scientific, Bio-Rad Laboratories, PerkinElmer, Inc., and Promega Corporation, which dominate the market due to their broad product portfolios and strong R&D capabilities. These companies offer a wide range of consumables and instruments for various applications, including drug discovery, stem cell research, and clinical diagnostics. The market is also witnessing increased collaborations, mergers, and acquisitions to expand product offerings and geographic presence. Smaller players are focusing on niche applications and innovation to gain market share. Companies are investing in the development of advanced, high-throughput cell viability assays to cater to the growing demand for personalized medicine and targeted therapies. The increasing emphasis on research and development activities, along with the rise in funding for biotech innovations, contributes to heightened competition in the market.

Recent Developments:

In June 2023, Promega Corporation launched the MyGlo(TM) Reagent Reader, a portable 96-well plate reader tailored for luminescent assays, including the CellTiter-Glo assay for cell viability. This compact device offers a wide dynamic range and enhances accessibility for researchers in various settings.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CELL VIABILITY ASSAYS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abcam plc
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biotium
  • BioVision, Inc.
  • Cayman Chemical Company
  • Cell Biolabs, Inc.
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories
  • Creative Bioarray
  • Merck KGaA
  • PerkinElmer, Inc.
  • Promega Corporation
  • Sigma-Aldrich (Merck)
  • Thermo Fisher Scientific, Inc.
  • Others

GLOBAL CELL VIABILITY ASSAYS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Consumables
  • Reagents
  • Assay Kits
  • Dye exclusion assays
  • Colorimetric assays
  • Fluorometric assays
  • Luminometric assays
  • Microplates
  • Instruments
  • Spectrophotometer
  • Microscopy
  • Cell imaging and analysis system
  • Flow Cytometry
  • Others

GLOBAL CELL VIABILITY ASSAYS MARKET, BY CELL TYPE- MARKET ANALYSIS, 2019 - 2032

  • Human cells
  • Microbial cells

GLOBAL CELL VIABILITY ASSAYS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Discovery and Development
  • Stem Cell Research
  • Clinical and Diagnostic Applications
  • Other

GLOBAL CELL VIABILITY ASSAYS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Research Institutes and Academic Centers
  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Clinics
  • Others

GLOBAL CELL VIABILITY ASSAYS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cell Viability Assays Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cell Viability Assays Market Snippet by Product Type
    • 2.1.2. Cell Viability Assays Market Snippet by Cell Type
    • 2.1.3. Cell Viability Assays Market Snippet by Application
    • 2.1.4. Cell Viability Assays Market Snippet by End-User
    • 2.1.5. Cell Viability Assays Market Snippet by Country
    • 2.1.6. Cell Viability Assays Market Snippet by Region
  • 2.2. Competitive Insights

3. Cell Viability Assays Key Market Trends

  • 3.1. Cell Viability Assays Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cell Viability Assays Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cell Viability Assays Market Opportunities
  • 3.4. Cell Viability Assays Market Future Trends

4. Cell Viability Assays Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cell Viability Assays Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Cell Viability Assays Market Landscape

  • 6.1. Cell Viability Assays Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cell Viability Assays Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Consumables
      • 7.1.2.1. Reagents
      • 7.1.2.2. Assay Kits
      • 7.1.2.2.1. Dye exclusion assays
      • 7.1.2.2.2. Colorimetric assays
      • 7.1.2.2.3. Fluorometric assays
      • 7.1.2.2.4. Luminometric assays
      • 7.1.2.3. Microplates
    • 7.1.3. Instruments
      • 7.1.3.1. Spectrophotometer
      • 7.1.3.2. Microscopy
      • 7.1.3.3. Cell imaging and analysis system
      • 7.1.3.4. Flow Cytometry
    • 7.1.4. Others

8. Cell Viability Assays Market - By Cell Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Cell Type, 2024 & 2032 (%)
    • 8.1.2. Human cells
    • 8.1.3. Microbial cells

9. Cell Viability Assays Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Drug Discovery and Development
    • 9.1.3. Stem Cell Research
    • 9.1.4. Clinical and Diagnostic Applications
    • 9.1.5. Other

10. Cell Viability Assays Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 10.1.2. Research Institutes and Academic Centers
    • 10.1.3. Pharmaceutical and Biotechnology Companies
    • 10.1.4. Hospitals and Clinics
    • 10.1.5. Others

11. Cell Viability Assays Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Cell Viability Assays Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Cell Viability Assays Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Cell Viability Assays Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Cell Viability Assays Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Cell Viability Assays Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Cell Viability Assays Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Abcam plc
    • 12.2.2. Agilent Technologies, Inc.
    • 12.2.3. Bio-Rad Laboratories, Inc.
    • 12.2.4. Biotium
    • 12.2.5. BioVision, Inc.
    • 12.2.6. Cayman Chemical Company
    • 12.2.7. Cell Biolabs, Inc.
    • 12.2.8. Cell Signaling Technology, Inc.
    • 12.2.9. Charles River Laboratories
    • 12.2.10. Creative Bioarray
    • 12.2.11. Merck KGaA
    • 12.2.12. PerkinElmer, Inc.
    • 12.2.13. Promega Corporation
    • 12.2.14. Sigma-Aldrich (Merck)
    • 12.2.15. Thermo Fisher Scientific, Inc.
    • 12.2.16. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us